Literature DB >> 26202316

Efficacy of intravenous immunoglobulins in a patient with systemic lupus erythematosus presenting with Stevens-Johnson syndrome.

Irma L Vázquez-Sanabria1, Rogelio Mercado-Seda2, Noemí Varela-Rosario1, Luis M Vilá1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26202316      PMCID： PMC4513524          DOI： 10.1136/bcr-2015-211157

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

Review 1.  The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome.

Authors:  Jeffrey J Bidinger; Karen Sky; Daniel F Battafarano; J Scott Henning
Journal:  J Am Acad Dermatol       Date:  2011-04-15       Impact factor: 11.527

2.  Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.

Authors:  Maurizio Stella; Alessandra Clemente; Daniele Bollero; Daniela Risso; Paola Dalmasso
Journal:  Burns       Date:  2007-05-01       Impact factor: 2.744

Review 3.  Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.

Authors:  M Ziemer; S H Kardaun; Y Liss; M Mockenhaupt
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302
  3 in total
  2 in total

1.  Cephalosporin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin.

Authors:  Konstantin Boroda; Li Li; Louis Riina; Shadab Ahmed
Journal:  Cureus       Date:  2015-10-21

2.  Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015.

Authors:  Waleed M Sweileh
Journal:  Orphanet J Rare Dis       Date:  2017-01-18       Impact factor: 4.123
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.